
News|Slideshows|September 26, 2024
Emerging Research in Prostate Cancer Imaging — September 2024
Author(s)Diagnostic Imaging Staff
Catch up on the most-well viewed prostate imaging content in September 2024.
Advertisement
Touching on a variety of topics in prostate cancer imaging, ranging from Phase 3 trial results for 177Lu-PSMA-617 in taxane-naïve patients with mCRPC to a new meta-analysis comparing PSMA PET/CT to mpMRI in detecting biomechanical recurrence of PCa, here are the top five most well-viewed prostate imaging content from Diagnostic Imaging for September 2024.
Advertisement
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
SCCT: Should Photon-Counting CT Be the New Standard for Assessing CAD Prior to TAVR?
2
FDA Clears AI-Enabled Ultrasound for High-Volume Clinical Settings
3
Diagnostic Imaging's Weekly Scan: July 5 — July 11
4
Interventional Radiology in Focus: A Closer Look at Y90 Radioembolization for Patients with Liver Cancer
5













